We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $1.25M | ﹤0.01% |
102,816
-670
| -0.6% | -$8.72K |
|
|
AKUS
2877
DELISTED
Akouos Inc
AKUS
| $1.25M | ﹤0.01% |
99,753
-25,397
| -20% | -$304K |
|
|
GPX
2878
DELISTED
GP Strategies Corp.
GPX
| $1.25M | ﹤0.01% |
60,419
-9,498
| -14% | -$188K |
|
2879
Utah Medical Products
UTMD
$225M
| $1.25M | ﹤0.01% |
14,029
-1,620
| -10% | -$143K |
|
|
MTEM
2880
DELISTED
Molecular Templates, Inc.
MTEM
| $1.25M | ﹤0.01% |
12,381
-439
| -3% | -$45.3K |
|
|
TA
2881
DELISTED
TravelCenters of America LLC
TA
| $1.24M | ﹤0.01% |
27,606
+7,515
| +37% | +$281K |
|
2882
Eterna Therapeutics
ERNA
$4.91M
| $1.24M | ﹤0.01% |
14
-23
| -62% | -$1.99M |
|
|
APLT
2883
DELISTED
Applied Therapeutics
APLT
| $1.24M | ﹤0.01% |
74,466
-16,993
| -19% | -$293K |
|
2884
Centrus Energy
LEU
$3.82B
| $1.23M | ﹤0.01% |
33,491
+5,763
| +21% | +$160K |
|
2885
Rimini Street
RMNI
$471M
| $1.23M | ﹤0.01% |
125,162
+17,317
| +16% | +$150K |
|
|
ESPR
2886
DELISTED
Esperion Therapeutics
ESPR
| $1.23M | ﹤0.01% |
98,114
-67,884
| -41% | -$988K |
|
2887
Tilly's
TLYS
$128M
| $1.23M | ﹤0.01% |
84,285
-10,001
| -11% | -$152K |
|
2888
N-able
NABL
$940M
| $1.22M | ﹤0.01% |
+98,559
| New | +$1.35M |
|
|
GNTY
2889
DELISTED
Guaranty Bancshares
GNTY
| $1.22M | ﹤0.01% |
35,956
-1,864
| -5% | -$63.3K |
|
2890
Park Aerospace
PKE
$819M
| $1.22M | ﹤0.01% |
89,307
-4,916
| -5% | -$72.1K |
|
2891
Cue Biopharma
CUE
$114M
| $1.22M | ﹤0.01% |
3,151
-57
| -2% | -$19.9K |
|
2892
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
| $1.21M | ﹤0.01% |
21,300
| – | – |
|
2893
Red Robin
RRGB
$152M
| $1.21M | ﹤0.01% |
53,260
-68,187
| -56% | -$1.76M |
|
2894
Autoliv
ALV
$9B
| $1.21M | ﹤0.01% |
14,106
-84,772
| -86% | -$7.82M |
|
|
TCRR
2895
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $1.21M | ﹤0.01% |
120,807
+4,043
| +3% | +$57.1K |
|
2896
iBio
IBIO
$70M
| $1.2M | ﹤0.01% |
1,956
+19
| +1% | +$11.8K |
|
2897
Artesian Resources
ARTNA
$358M
| $1.2M | ﹤0.01% |
31,508
-4,738
| -13% | -$182K |
|
|
DRRX
2898
DELISTED
DURECT Corp
DRRX
| $1.2M | ﹤0.01% |
91,220
-2,031
| -2% | -$27.6K |
|
2899
Northrim BanCorp
NRIM
$587M
| $1.19M | ﹤0.01% |
123,016
-3,904
| -3% | -$40.3K |
|
|
SQZ
2900
DELISTED
SQZ Biotechnologies Company
SQZ
| $1.19M | ﹤0.01% |
82,450
-2,729
| -3% | -$37K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.